Inhibition of thioredoxin signalling by alkyl and aryl 2-imidazolyl disulfide compounds as potential antitumor agents

Persistent Link:
http://hdl.handle.net/10150/282694
Title:
Inhibition of thioredoxin signalling by alkyl and aryl 2-imidazolyl disulfide compounds as potential antitumor agents
Author:
Angulo-Escalante, Miguel Angel, 1962-
Issue Date:
1998
Publisher:
The University of Arizona.
Rights:
Copyright © is held by the author. Digital access to this material is made possible by the University Libraries, University of Arizona. Further transmission, reproduction or presentation (such as public display or performance) of protected items is prohibited except with permission of the author.
Abstract:
This work describes (1) the identification of alkyl and aryl 2-imidazolyl disulfides that inhibit growth in human cancer cell lines, (2) examines the antitumor activities of these disulfides in xenografted scid mice, (3) characterizes the chemopreventive activity in min mice of the disulfides IV-2, and (4) suggests the potential mechanisms by which these compounds mediate their actions. The alkyl and aryl 2-imidazolyl disulfides are inhibitors of the TR/Trx which regulates cell growth in both normal and cancer cells and is constitutively activated in a number of human primary cancers (Berggren, 1996). We found that all of the disulfides tested were potent inhibitors of growth in a panel of 60 cancer cell lines tested by the NCI. Disulfides IV-2, VI-2, and DLK-36 were found to inhibit growth of HL-60 leukemia and MCF-breast cancer cells implanted in scid mice. However, these disulfides had no significant inhibitory effect on the growth of human HT-29 colon cancer cells implanted in scid mice. Disulfide IV-2 also demonstrated a chemopreventive activity evaluated in min mice fed diet supplemented with 250 ppm IV-2. These disulfides may function through modulation of cellular redox status. It was determined that disulfides IV-2 and DLK-36 decreased GSH levels and that this effect may be due to indirect inhibition of the TR/Trx redox system or a direct reaction of GSH with the disulfides. Importantly, Human Trx regulates transcription factors such as NF-KB and activation of this transcription factor protects cells from apoptosis. Disulfide IV-2 was observed to inhibit the transcriptional activity of NF-KB. This inhibitory activity may sensitize cells to apoptosis. Most of the disulfides tested induced apoptosis at concentrations of twice the IC50 in both MCF-7 breast and HT-20 colon cancer cells. Interestingly, a protein which is secreted by MCF-7 cells into the media can degrade disulfide IV-2. This putative molecule has a molecular weight (m.w) greater than 3000 and is likely redox sensitive because ultra-filtered conditioned media (3000 m.w.) or aged media drastically decreased the degradation or sequestration activity of conditioned media. Plasma from mice treated with disulfides IV-2 or DLK-36 (i.v.) gave the same HPLC profile as seen in in vitro studies. These disulfides could be inhibiting tumor growth by inhibition of the TR/Trx system and/or depletion of GSH. Finally, the p53 tumor suppressor protein appears to be regulated by redox conditions. Recent, evidence suggests p53 may be regulated specifically by the TR redox system. The rat embryo fibroblast cell line, Al-5, expressing wild-type p53 was less sensitive to disulfides than these same cells expressing mutant p53.
Type:
text; Dissertation-Reproduction (electronic)
Keywords:
Health Sciences, Pharmacology.
Degree Name:
Ph.D.
Degree Level:
doctoral
Degree Program:
Graduate College; Pharmacology and Toxicology
Degree Grantor:
University of Arizona
Advisor:
Powis, Garth

Full metadata record

DC FieldValue Language
dc.language.isoen_USen_US
dc.titleInhibition of thioredoxin signalling by alkyl and aryl 2-imidazolyl disulfide compounds as potential antitumor agentsen_US
dc.creatorAngulo-Escalante, Miguel Angel, 1962-en_US
dc.contributor.authorAngulo-Escalante, Miguel Angel, 1962-en_US
dc.date.issued1998en_US
dc.publisherThe University of Arizona.en_US
dc.rightsCopyright © is held by the author. Digital access to this material is made possible by the University Libraries, University of Arizona. Further transmission, reproduction or presentation (such as public display or performance) of protected items is prohibited except with permission of the author.en_US
dc.description.abstractThis work describes (1) the identification of alkyl and aryl 2-imidazolyl disulfides that inhibit growth in human cancer cell lines, (2) examines the antitumor activities of these disulfides in xenografted scid mice, (3) characterizes the chemopreventive activity in min mice of the disulfides IV-2, and (4) suggests the potential mechanisms by which these compounds mediate their actions. The alkyl and aryl 2-imidazolyl disulfides are inhibitors of the TR/Trx which regulates cell growth in both normal and cancer cells and is constitutively activated in a number of human primary cancers (Berggren, 1996). We found that all of the disulfides tested were potent inhibitors of growth in a panel of 60 cancer cell lines tested by the NCI. Disulfides IV-2, VI-2, and DLK-36 were found to inhibit growth of HL-60 leukemia and MCF-breast cancer cells implanted in scid mice. However, these disulfides had no significant inhibitory effect on the growth of human HT-29 colon cancer cells implanted in scid mice. Disulfide IV-2 also demonstrated a chemopreventive activity evaluated in min mice fed diet supplemented with 250 ppm IV-2. These disulfides may function through modulation of cellular redox status. It was determined that disulfides IV-2 and DLK-36 decreased GSH levels and that this effect may be due to indirect inhibition of the TR/Trx redox system or a direct reaction of GSH with the disulfides. Importantly, Human Trx regulates transcription factors such as NF-KB and activation of this transcription factor protects cells from apoptosis. Disulfide IV-2 was observed to inhibit the transcriptional activity of NF-KB. This inhibitory activity may sensitize cells to apoptosis. Most of the disulfides tested induced apoptosis at concentrations of twice the IC50 in both MCF-7 breast and HT-20 colon cancer cells. Interestingly, a protein which is secreted by MCF-7 cells into the media can degrade disulfide IV-2. This putative molecule has a molecular weight (m.w) greater than 3000 and is likely redox sensitive because ultra-filtered conditioned media (3000 m.w.) or aged media drastically decreased the degradation or sequestration activity of conditioned media. Plasma from mice treated with disulfides IV-2 or DLK-36 (i.v.) gave the same HPLC profile as seen in in vitro studies. These disulfides could be inhibiting tumor growth by inhibition of the TR/Trx system and/or depletion of GSH. Finally, the p53 tumor suppressor protein appears to be regulated by redox conditions. Recent, evidence suggests p53 may be regulated specifically by the TR redox system. The rat embryo fibroblast cell line, Al-5, expressing wild-type p53 was less sensitive to disulfides than these same cells expressing mutant p53.en_US
dc.typetexten_US
dc.typeDissertation-Reproduction (electronic)en_US
dc.subjectHealth Sciences, Pharmacology.en_US
thesis.degree.namePh.D.en_US
thesis.degree.leveldoctoralen_US
thesis.degree.disciplineGraduate Collegeen_US
thesis.degree.disciplinePharmacology and Toxicologyen_US
thesis.degree.grantorUniversity of Arizonaen_US
dc.contributor.advisorPowis, Garthen_US
dc.identifier.proquest9901646en_US
dc.identifier.bibrecord.b38783447en_US
All Items in UA Campus Repository are protected by copyright, with all rights reserved, unless otherwise indicated.